Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

Simona Sica

doi:10.1007/s00277-018-3535-y

Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients

Lingua originale	English
pagine (da-a)	190-191
Numero di pagine	2
Rivista	Transfusion and Apheresis Science
DOI	https://doi.org/10.1007/s00277-018-3535-y
Stato di pubblicazione	Pubblicato - 2019

Keywords

We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients

Accesso al documento

10.1007/s00277-018-3535-y

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{da1e23035c93440b9fd2d5800f154096,

title = "Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience",

abstract = "We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients",

keywords = "We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients, We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients",

author = "Simona Sica",

year = "2019",

doi = "10.1007/s00277-018-3535-y",

language = "English",

pages = "190--191",

journal = "Transfusion and Apheresis Science",

issn = "1473-0502",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

AU - Sica, Simona

PY - 2019

Y1 - 2019

N2 - We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients

AB - We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a colonization rate of 6.5% at admission, with a 16% probability of MDR-related bloodstream infection (BSI), particularly in neutropenic patients. Among them, a carbapenem-resistant gram-negative bacteria was responsible for the 59% of the colonized patients

KW - We have read with interest the paper conducted by the SEIFEM group, concerning the severe problem of multidrug-resistant (MDR) infection in the hematological setting. In a multicentric prospective observational study, Cattaneo and colleagues recorded a co

UR - http://hdl.handle.net/10807/155703

U2 - 10.1007/s00277-018-3535-y

DO - 10.1007/s00277-018-3535-y

M3 - Article

SN - 1473-0502

SP - 190

EP - 191

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

ER -

Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo